![]() BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. | Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. | Cellabs Cellabs is a biotechnology company specializing in the design, development, and manufacture of immunodiagnostic kits for tropical and infectious diseases. | ||
Founding Date | Founding Date 1986 | Founding Date 1975 | Founding Date 1985 | Founding Date 2000 |
Type | Type Public | Type Subsidiary | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Durham, US HQ Hoover, US | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES | Locations Brookvale, AU HQ | Locations Planegg, DE HQ Cambridge, US |
Employees | Employees 14040% increase | Employees 332 | Employees N/A | Employees 147 |
Financial | ||||
Revenue (est.) | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) $346.7m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $19.1m (FY, 2025) | Cost of goods $190.3m (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $855.8m (FY, 2025) | Gross profit $156.4m (FY, 2018) | Gross profit N/A | Gross profit N/A |
Net income | Net income $263.9m (FY, 2025) | Net income $40.5m (FY, 2018) | Net income N/A | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 1.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7m |
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View companyCellabs is a biotechnology company specializing in the design, development, and manufacture of immunodiagnostic kits for tropical and infectious diseases.
View company
Proteros biostructures is a company that provides early-stage drug discovery services.
View company